Becker's Healthcare February 14, 2023
HHS is taking aim at high prescription drug costs through three new programs announced Feb. 14.
The models are designed to make medications more affordable for Medicare and Medicaid recipients and the CMS Innovation Center will test them. The three models are:
1. The Medicare $2 Drug List, also called the Medicare High-Value Drug List Model: Under this model, CMS would encourage Medicare Part D plans to offer a low, fixed copay — across all four phases of cost-sharing — for a standardized list of generic drugs used to treat chronic illnesses.
“Patients picking plans that participate in the model will have more certainty that their out-of-pocket costs for these generic drugs will be capped at a maximum of...
Today's Sponsors
Today's Sponsor